FDA’s QMSR – Key Update for Medical Device Manufacturers

FDA’s QMSR replaces the old Quality System Regulation (QSR) and aligns U.S. medical device quality rules with ISO 13485:2016. The FDA’s QMSR was finalized in February 2024, and compliance is mandatory by February 2, 2026.

Why FDA’s QMSR Matters

The main goal of FDA’s QMSR is global harmonization. By aligning with ISO 13485:2016, FDA’s QMSR reduces duplicate audits, improves efficiency, and supports better patient safety while making global market access easier.

Key Changes Under FDA’s QMSR

• Updated Terminology: DMR, DHR, and DHF are replaced with Medical Device File and Design & Development File. Documentation remains mandatory under FDA’s QMSR.

• Records Control: FDA’s QMSR requires stronger traceability, including UDI/UPC in complaint and service records.

• Risk Management: FDA’s QMSR integrates risk-based decision-making across design, purchasing, manufacturing, and CAPA.

• Labeling & Packaging: FDA-specific labeling controls remain applicable under FDA’s QMSR, taking precedence where conflicts exist.

What Manufacturers Should Do

Medical device companies must update their Quality Management System to meet FDA’s QMSR requirements. Early transition planning ensures smooth compliance, stronger quality systems, and improved regulatory readiness.